MENU
NBIX
AS OF
Nov 13, 04:59 PM (EDT)
Price
$144.10
Change
-$2.75 (-1.87%)
Capitalization
14.64B
90 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
NBIX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Neurocrine Biosciences (NBIX) Earnings Date & Reports

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

NBIX is expected to report earnings to fall 16.59% to $1.81 per share on February 11

Neurocrine Biosciences NBIX Stock Earnings Reports
Q4'25
Est.
$1.81
Q3'25
Beat
by $0.58
Q2'25
Beat
by $0.69
Q1'25
Missed
by $0.07
Q4'24
Beat
by $0.12
The last earnings report on October 28 showed earnings per share of $2.17, beating the estimate of $1.59. With 322.27K shares outstanding, the current market capitalization sits at 14.64B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
NBIX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NBIX showed earnings on October 28, 2025. You can read more about the earnings report here.
View AI-Driven Trading for NBIX
A.I. Advisor
published General Information

General Information

a product based biopharmaceutical company

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Biotechnology
Address
12780 El Camino Real
Phone
+1 858 617-7600
Employees
1400
Web
https://www.neurocrine.com